Literature DB >> 213084

Apoprotein A metabolism in Tangier disease.

G Assmann, A Capurso, E Smootz, U Wellner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 213084     DOI： 10.1016/0021-9150(78)90125-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  8 in total

1.  [Tangier-disease (author's transl)].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1979-01-15

2.  Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.

Authors:  M Walter; H Reinecke; U Gerdes; J R Nofer; G Höbbel; U Seedorf; G Assmann
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

3.  Isolation and characterization of cDNA clones for human apolipoprotein A-I.

Authors:  J L Breslow; D Ross; J McPherson; H Williams; D Kurnit; A L Nussbaum; S K Karathanasis; V I Zannis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

4.  Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.

Authors:  G Schmitz; G Assmann; S C Rall; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

5.  Tangier disease: a disorder of intracellular membrane traffic.

Authors:  G Schmitz; G Assmann; H Robenek; B Brennhausen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

6.  Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).

Authors:  L L Kay; R Ronan; E J Schaefer; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide.

Authors:  V I Zannis; S K Karathanasis; H T Keutmann; G Goldberger; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).

Authors:  E J Schaefer; L L Kay; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.